

HY-125059 · 50 mg
MedChemExpress · Cat: HY-125059
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/ptc-510-free-base.htmlDescription
PTC-510 Free base is a compound that selectively inhibits hypoxia-induced VEGF expression in tumor cells. PTC-510 Free base demonstrates potent activity in reducing endogenous VEGF production under hypoxic conditions. PTC-510 Free base has been shown to control tumor growth effectively while minimizing toxicity. PTC-510 Free base represents a novel therapeutic strategy to address the limitations of current anti-VEGF therapies.







